Search

everythinglearnresearchcommunity

for

Search:↓

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.